Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center

    Forecasted

    This grant will fund a center to develop and test innovative diagnostic tools for rare and undiagnosed diseases, collaborating with national networks and using advanced genomic and non-genomic approaches.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating Center

    This grant will fund a center to coordinate patient support, data management, research, and collaboration for advancing diagnosis and care of individuals with undiagnosed diseases through the Undiagnosed Diseases Network.

    HHS-NIH11Forecasted May 25, 2027Forecasted

    Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence

    This grant supports regional clinical networks to improve diagnosis of rare, hard-to-diagnose diseases through multidisciplinary collaboration, innovative tools, and expanded access as part of the Undiagnosed Diseases Network.

    HHS-NIH11Forecasted May 25, 2027Forecasted

    Notice of Intent to Publish a Funding Opportunity Announcement for Diabetes Research Centers (P30 Clinical Trial Optional)

    NIDDK plans to fund Diabetes Research Centers (P30) to foster collaboration, mentoring, and innovative research resources for advancing diabetes and metabolic disorder research.

    HHS-NIH11Due Jan 27, 2027$5,000,000Limited submission

    NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)

    This grant funds centers that provide specialized research services and training to external investigators in areas related to NIDDK’s mission, such as obesity and diabetes, to enhance research rigor and efficiency.

    HHS-NIH11Forecasted Jan 28, 2027$9,000,000Forecasted

    Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

    NIH funds testing centers to evaluate the safety and efficacy of somatic cell genome editing for human disease therapies using preclinical models; clinical trials are not allowed.

    HHS-NIH11Forecasted Jan 25, 2028$900,000Forecasted